RCERT SDN BHD
- Home
- RCERT SDN BHD
About Us
About Us - RCERT Sdn Bhd (Regional Cell Research & Therapy Centre)
Regional Cell Research & Therapy Centre (RCERT) is a biotechnology company focused on developing current and future technical know-how related to the development, engineering, and clinical application of cell therapies to serve the regional community and create a brighter future for mankind.
RCERT Sdn Bhdaims to become the most comprehensive leader in cell research and therapy in Southeast Asia, offering preventive healthcare, regenerative medicine, cell therapy, immunotherapy, research, and contemporary cell culture laboratory services.
Today, cell therapy continues to evolve with ongoing investigations for clinical safety and efficacy, and with a global market size estimated to expand from USD 9.5 billion in 2021 to USD 23.0 billion in 2028.
UNIMAS & RCERT SDN BHD SIGNING MOU
Our Key Strengths
Advanced Cell Processing Laboratory (cGMP Status)
Clinical Collaboration with UNIMAS Sarawak
International technology transfer partnership with Zhongrong Cell Technology Center, China
Comprehensive portfolio: Mesenchymal Stem Cells, Exosomes, Mitochondria Therapy, Cancer Immunotherapy, Anti-Aging Programs, and Research Laboratories
Experienced medical leadership and advisory team across multiple specialties
Our Vision
Our Mission
International Technology Partner
Zhongrong Cell Technology Center, China
Established in 2012, Zhongrong is engaged in cutting-edge medical research and applications of gene technology, cell technology, regenerative medicine, tissue engineering, 3D reconstruction technology, and Nobel Prize-level scientific transformation. The partnership allows RCERT Sdn Bhd to access advanced technology, knowledge transfer, and clinical applications.
Our Team
Meet Our Expert Team
Our leadership combines medical, scientific, and business expertise from Malaysia and internationally. RCERT Sdn Bhd is guided by an experienced Board of Directors, renowned physicians, and leading research scientists committed to advancing cell therapy and regenerative medicine.
Dato’ Seri Dr. Chen Chaw Min
CHAIRMAN
Dr. Lim Chin Seng
MEDICAL DIRECTOR
Mr. Loh Sheng Wei (Vin)
CHIEF EXECUTIVE OFFICER (CEO)
Mr. Tan Kam Foo
MARKETING DIRECTOR
Dr. Bai Zheng Zhong
CHIEF INTERNATIONAL SCIENTIST